Novel 3,5- disubstituted-2-isoxazoline derivatives; synthesis, antimicrobial evaluation, and docking study

Abstract

One of the most significant issues confronting public health from around world today is antimicrobial resistance., generated by excess of the antimicrobial activities. To counteract the significant infection induced by these probable bacteria that are resistant to current state egent, new antimicrobial pharmaceuticals are still certainly needed. This study aimed to synthesize isoxazoline derivatives as potential antibacterial agents and to examine their early structure activity correlations (SARS). The antibacterial activity of the compounds that were tested against a wide variety of bacteria and microorganisms was determined through the use of an experiment called cup-plate agar diffusion. These infections were caused by an antifungal, a gram-negative (Escherichia coli and Pseudomonas aeruginosa), a gram-positive (Staphylococcus aureus and Bacillus subtilis), and a gram-negative (Escherichia coli and Pseudomonas aeruginosa) pathogenic (Candida albicans) . All of the most compound active were docked program into glucosamine-6-phosphate synthase (GlcN-6-P), the antibacterial drug's molecular the target enzyme via the Autodock 4.2 program. The reaction of Shiffs bases of derivatives (16 and 17) with 2-mercaptoacetic acid resulted in the synthesis of two beta lactam derivatives (21,22). The imine derivatives (16, 20) reacted with furan2,5-dione to generate oxazepine derivatives (23, 24). There is evidence to suggest that the recently synthesized heterocyclic compounds will prove to be effective trying to jump points for the studies that will lead to the development of new antibacterial therapeutics.